SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001999371-24-009272
Filing Date
2024-07-30
Accepted
2024-07-30 17:08:39
Documents
16
Period of Report
2024-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_073024.htm   iXBRL 8-K 29314
2 SALES AGREEMENT ex1-01.htm EX-1.01 285242
3 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-01.htm EX-5.01 13570
7 GRAPHIC ex5-01_img001.gif GRAPHIC 1942
  Complete submission text file 0001999371-24-009272.txt   572366

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE txnp-20240730.xsd EX-101.SCH 3024
5 XBRL LABEL FILE txnp-20240730_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE txnp-20240730_pre.xml EX-101.PRE 22365
18 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_073024_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 241158682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)